Navigation Links
Cytopia Commences Second Phase II Study in Brain Cancer
Date:9/4/2008

MELBOURNE, Australia, Sept. 4 /PRNewswire/ -- Cytopia Limited (ASX: CYT) today announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).

The GBM clinical trial is the first Phase II efficacy study in highly vascular, solid tumor indications for the company and the second in its suite of Phase II studies designed to investigate the anticancer activity of CYT997. Patient recruitment to the study will now commence, following regulatory approval in Australia and the United States.

The clinical study will investigate the activity of CYT997 in combination with two other marketed anticancer agents in approximately 30 patients at a number of clinical centres in Australia and overseas. Dr Jason Lickliter, Director of Oncology at the Frankston Hospital, will be Study Chairman for the program.

GBM is currently treated by surgical resection, and/or radiation and chemotherapy. Despite these treatments, the condition recurs in most patients, leading to a poor prognosis and median survival of less than 12 months. GBM tumors are highly vascular and heavily dependent on their own abnormal blood supply for growth, rendering them potentially susceptible to destruction by an anti-vascular agent such as CYT997.

The following table provides a summary of the key aspects of the Phase II GBM trial.

Name of trial A Phase Ib/II Study of CYT997 in Combination with

Carboplatin and Etoposide in Relapsed Glioblastoma

Multiforme (CCL08001).

Primary endpoints Assess safety and tolerability of escalating doses

of CYT997 given in combination with standard

carboplatin and etoposide therapy (Ph Ib), and

estimation of progress
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
3. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
4. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
5. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
6. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
7. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
8. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
9. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
10. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
11. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Sept. 7, 2011 The Long Term Care Pharmacy ... Medicare D Residents in Skilled Nursing Facilities," has been ... Pharmacist, the official peer-reviewed journal of the American Society ... study to measure the quantity and the value of ...
... HEWA) a leading VIPPS accredited retail mail-order pharmacy, today ... will present at the Kaufman Brothers 14th Annual Investor ... Time on September 7, 2011. The public ... of the presentation on the Investor Relations section of ...
Cached Medicine Technology:LTCPA Study Quantifying Unused Medicare Part D Drugs in Skilled Nursing Facilities Published in The Consultant Pharmacist 2
(Date:8/31/2014)... 2014 This September, California Library ... Library, celebrates 30 years of changing the lives ... inception, California’s Library Literacy Services has helped nearly ... read and write. , To mark the 30th ... is launching a month-long awareness campaign titled “Together, ...
(Date:8/31/2014)... Spain Sunday 31 August 2014: Wine only protects ... to results from the In Vino Veritas (IVV) study ... from the Czech Republic. , Professor Taborsky said: "This ... red and white wine on markers of atherosclerosis (1) ... We found that moderate wine drinking was only protective ...
(Date:8/30/2014)... 31 August 2014: A retrievable and repositionable transcatheter ... real world setting, according to research presented at ... from Germany. The direct flow medical (DFM) transcatheter ... control and has the potential to improve transcatheter ... severe aortic stenosis. , Dr Pyxaras said: "TAVI ...
(Date:8/30/2014)... In a world where a typical response to conflict is ... a game app to teach another way. Launched in ... is a colorful way to encourage moral values playfully. ... double-duty by teaching players new ways to find happiness and ... for consistently taking the high road, the Ultimate Karma game ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 Recently, ... many web hosting companies and announced that BlueHost ... suppliers for webmasters who want to buy high ... we recommend are the best web host companies ... and server speed with top-level support.” A spokesman ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Wine only protects against CVD in people who exercise 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2
... team has discovered a new protein family that may play ... some forms of cancer and even heart disease. , The ... system are published in the March 7 edition of the ... the National Institutes of Health. , What we found is ...
... MS Awareness Week March,10 - 17 unites MS organizations ... nationwide in an effort to shine a spotlight on ... disease where someone is,newly diagnosed each hour., (Logo: ... Ways To Join The MS Movement, The ...
... Hib meningitis has been virtually eliminated in,young children ... introduced Haemophilus influenzae type,b (Hib) vaccine nationwide, according ... b is a leading cause of pneumonia and ... and spinal cord. Each year, Hib kills approximately ...
... the charge in adapting drug dosing to a society ... of obesity in the Western World continues to rise ... researchers face the ongoing challenge of determining just how ... compositions. , In a pharmacological sense, obesity presents ...
... Carell, Stephen, Colbert, Susie Essman, Will Ferrell, Tina Fey, Jonah Hill, Kevin ... Triumph The Insult Comic Dog And Many More To Be ... And xBox Live, Marketplace For $1.99 For 30 Days After Airdate With All ... ...
... Patient Care and Reduced Costs for Hospitals by ... Service Delivery with Significant ROI, DETROIT, March ... launched a new initiative to provide hospitals and,physicians ... dynamically,changing healthcare technology environment. By proactively managing service,delivery ...
Cached Medicine News:Health News:UCF researchers discover a new protein family implicated in inflammatory diseases 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 2Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 3Health News:What Will You Do? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17 4Health News:Deadly disease eliminated in children under 5 years of age in Uganda 2Health News:Deadly disease eliminated in children under 5 years of age in Uganda 3Health News:Deadly disease eliminated in children under 5 years of age in Uganda 4Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 3Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 2Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 3
For use with catalog #0540, 0887....
For use with catalog #0540....
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Medicine Products: